Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Exchange Rate Effect of -$130000.0 for Q1 2026, down 103.12% year-over-year from $4.2 million in Q1 2025, and down 25.0% quarter-over-quarter from -$104000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Exchange Rate Effect for 14 consecutive years, with -$130000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 103.12% year-over-year to -$130000.0; the TTM figure through Mar 2026 stood at $392000.0 (up 128.63% YoY), while the FY2025 annual figure was $458000.0, up 127.39% from the prior year.
- Exchange Rate Effect declined to -$130000.0 in Q1 2026 per XENE's latest filing, from -$104000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $814000.0 in Q4 2022 and bottomed at -$2.7 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$203058.8 across 5 years, with a median of -$64000.0 in 2025.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 1079.71% — and 2024, when it slumped 722.03%.
- Xenon Pharmaceuticals' Exchange Rate Effect stood at $814000.0 in 2022, then sank by 69.78% to $246000.0 in 2023, then tumbled by 570.33% to -$1.2 million in 2024, then soared by 91.01% to -$104000.0 in 2025, then retreated by 25.0% to -$130000.0 in 2026.
- Business Quant data shows XENE's Exchange Rate Effect at -$130000.0 in Q1 2026, -$104000.0 in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | 262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 262,000.00 |
| Jun 30, 2026 | 262,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Dec 31, 2025 | -104,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 632,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | -1.16 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | 54,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Jun 30, 2024 | -202,000.00 |
| Mar 31, 2024 | -367,000.00 |
| Mar 31, 2024 | -367,000.00 |